Group 2 innate lymphoid cells in nasal polyposis
Authors:
- 8 August 2020
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 126 (2) , 110-117
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 64 references indexed in Scilit:
- TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriersMucosal Immunology, 2014
- Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitisJournal of Allergy and Clinical Immunology, 2013
- Characterization of IL-18 Expression and Release in the Pathogenesis of Chronic RhinosinusitisInternational Archives of Allergy and Immunology, 2012
- The Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid CellsImmunity, 2012
- Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161Nature Immunology, 2011
- Reduced expression of COXs and production of prostaglandin E2 in patients with nasal polyps with or without aspirin-intolerant asthmaJournal of Allergy and Clinical Immunology, 2011
- Leukotriene modifiers for asthma treatmentClinical & Experimental Allergy, 2010
- Intracellular JNK, p38 MAPK and NF-κB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytesImmunology Letters, 2007
- Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposisJournal of Allergy and Clinical Immunology, 2005
- Urinary Leukotriene E4 Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic SubjectsAmerican Review of Respiratory Disease, 1991